Molecular Therapy - Methods and Clinical Development : Impact Factor & More
eISSN: 2329-0501pISSN: 2329-0501
Open AccessShare this on:
Key Metrics
CiteScore 
8.4
Impact Factor
< 5
SNIP
1.24
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Molecular Therapy - Methods and Clinical Development Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | CELL PRESS |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 3900 |
| Publication Time | 12 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | American Society of Gene & Cell Therapy |
| Frequency | Continuous publication |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Molecular Therapy - Methods and Clinical Development ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Molecular Therapy - Methods and Clinical Development
PH-dependent DNA degradation pathways for adeno-associated virus gene therapy.
- 1 Dec 2025
- Molecular therapy. Methods & clinical development
Intrathalamic delivery of adeno-associated viral vector expressing progranulin as gene therapy for GRN-related frontotemporal dementia.
- 1 Dec 2025
- Molecular therapy. Methods & clinical development
When pullulanase needs a little push: MyoAAV capsids enhance gene therapy for GSD IIIa
- 29 Nov 2025
- Molecular Therapy. Methods & Clinical Development
Why regulatory T cells love lactic acid
- 29 Nov 2025
- Molecular Therapy. Methods & Clinical Development
Rapid kinetics of AAV8 delivery of Vglut3 and hearing rescue shown day-by-day via matched IHC and ABR
- 27 Nov 2025
- Molecular Therapy. Methods & Clinical Development
Toward CAR-B cells for HIV-1 therapy
- 26 Nov 2025
- Molecular Therapy. Methods & Clinical Development
PH-dependent DNA degradation pathways for adeno-associated virus gene therapy.
- 1 Dec 2025
- Molecular therapy. Methods & clinical development
Intrathalamic delivery of adeno-associated viral vector expressing progranulin as gene therapy for GRN-related frontotemporal dementia.
- 1 Dec 2025
- Molecular therapy. Methods & clinical development
When pullulanase needs a little push: MyoAAV capsids enhance gene therapy for GSD IIIa
- 29 Nov 2025
- Molecular Therapy. Methods & Clinical Development
Why regulatory T cells love lactic acid
- 29 Nov 2025
- Molecular Therapy. Methods & Clinical Development
Rapid kinetics of AAV8 delivery of Vglut3 and hearing rescue shown day-by-day via matched IHC and ABR
- 27 Nov 2025
- Molecular Therapy. Methods & Clinical Development
Toward CAR-B cells for HIV-1 therapy
- 26 Nov 2025
- Molecular Therapy. Methods & Clinical Development
FAQs on Molecular Therapy - Methods and Clinical Development
How long has Molecular Therapy - Methods and Clinical Development been actively publishing? 
What is the publishing frequency of Molecular Therapy - Methods and Clinical Development?
How many articles did Molecular Therapy - Methods and Clinical Development publish last year?
What is the eISSN & pISSN for Molecular Therapy - Methods and Clinical Development?
What is Citescore for Molecular Therapy - Methods and Clinical Development?
What is SNIP score for Molecular Therapy - Methods and Clinical Development?
Who is the publisher of Molecular Therapy - Methods and Clinical Development?
